Flex Regen, Strawberry Kiwi – 400g
€15.73
The industrial-strength joint reconstruction matrix. Combines Collagen, Glucosamine, Chondroitin, MSM, and Turmeric to aggressively rebuild worn-out joint linings and eliminate chronic back pain.
8 in stock
Description
When standard multi-vitamins aren’t enough for your back pain, you need an intensive structural intervention. OstroVit Flex Regen is a comprehensive joint defense system. It pairs hydrolyzed collagen with a maximum-strength complex of Glucosamine, Chondroitin, and MSM to lubricate bone sockets, reduce joint friction, and lower structural inflammation. It is built specifically for night workers who routinely lift, turn, or assist immobile patients and require heavy-duty musculoskeletal support.
Nutritional information
Ingredients
Hydrolyzed bovine collagen, inulin, acidity regulator: malic acid; magnesium salts of citric acid, calcium carbonate, glucosamine sulfate 2KCL, methylsulfonylmethane, Boswellia serrata Roxb. ex Colebr. oleoresin extract - 65% boswellic acid, powdered beet juice concentrate, maltodextrin, L-proline, L-ascorbic acid, flavorings, chondroitin sulfate, thickening agents: xanthan gum, gum arabic; cholecalciferol, hyaluronic acid (sodium hyaluronate), anti-caking agent: silicon dioxide; sweetener: sucralose; pyridoxal 5'-phosphate, menaquinone-7 MK-7 derived from Bacillus subtilis natto.
Manufactured in a facility that uses ingredients derived from milk (including lactose), soy, and fish.
Nutrition Facts
Net weight of product: 400 gServings per container: 25Serving size: 16 g
Active ingredients
Per portion
% RI*
Hydrolysed bovine collagen
10 000 mg
-
Methylsulfonylmethane MSM
300 mg
-
Glucosamine sulphate 2KCL
300 mg
-
L-proline
200 mg
-
Calcium
120 mg
15%
Boswellia serrata oleoresin extract
246 mg
-
- of which boswellic acid (65%)
65 mg
-
Vitamin C
100 mg
125%
Magnesium
57 mg
15%
Chondroitin sulphate
40 mg
-
Hyaluronic acid
20 mg
-
Vitamin B6
1 mg
71%
Vitamin K
75 μg
100%
Vitamin D
50 μg
1000%
*RI - Reference intake
Reviews
There are no reviews yet.